跳至主要内容
临床试验/JPRN-UMIN000004790
JPRN-UMIN000004790已完成2 期

Prospective randomized study of efficacy of trancatheter arterial chemoembolizaion with miriplatin for hepatocellular carcinoma - Prospective randomized study of efficacy of trancatheter arterial chemoembolizaion with miriplatin for hepatocellular carcinoma

Kitasato University Scool of Medicine, Department of Gastroenterology0 个研究点目标入组 200 人开始时间: 2010年12月24日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Vascular invasion or bile duct invasion. 2) Extrahepatic metastasis. 3) Major arterioportal shunt in the liver. 4) Combination with locoregional therapy. 5) Hepatic encephalopathy or refractory ascites. 6) Adjuvant therapy with IFN, Vit A or anti cancer drug. 7) Patients who have medical history of hypersensitivity of iodine or contrast media. 8) Patients who have severe thyroid disease. 9) Patients who are pregnant, lactating or are suspected to be pregnant. 10) Patients who are concluded to be inappropriate to participate in this study by their physicians.

研究者

发起方
Kitasato University Scool of Medicine, Department of Gastroenterology

相似试验